echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Guangdong Medical Insurance Bureau issued a mass purchase notice covering 80% of large varieties of drugs

    Guangdong Medical Insurance Bureau issued a mass purchase notice covering 80% of large varieties of drugs

    • Last Update: 2021-05-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Yesterday, the Guangdong Provincial Medical Insurance Bureau issued a notice to solicit opinions on the implementation plan of Guangdong Pharmaceutical Group's mass procurement.


    It is planned to include the medicines in the medical insurance catalogue with the same generic name and the same dosage form in order of the purchase amount from high to low.


    The scope of this procurement is far beyond the scope of the TOP200 varieties previously circulated in the industry.


    The subjects participating in the bulk procurement of provincial drug groups are all public medical institutions (including military medical institutions, the same below), as well as voluntary medical insurance designated social medical institutions and designated pharmacies.


    Purchasing entities report the first year's purchase demand based on factors such as the amount of use in the previous year, the characteristics of clinical use, and the development of medical technology.


    In principle, public medical institutions will continue to purchase the selected products if the actual demand for drugs exceeds the agreed purchase amount.


    For generic drugs (referred to as over-rated drugs), original research drugs and reference preparations that have passed the consistency evaluation, no quality grouping is set up, and the same generic name and the same dosage form are directly used as the competition unit;

    For drugs that have not been covered by the consistency evaluation (referred to as non-over-rated drugs), in principle, no more than two drugs with the same generic name and the same dosage form shall be grouped in accordance with the requirements of quality and supply standards.


    In accordance with the reasonable price difference relationship, the different dosage forms, specifications, packaging and purchase quantities of the same generic drugs with similar clinical effects and the same route of administration are combined to promote competition.


    If the number of generic drugs with the same generic name and the same dosage form that have been evaluated on the online drug exceeds 3, the products that have not been evaluated will no longer be included in the provincial mass procurement and online procurement.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.